Assessment of Adipocyte Function in Women with PCOS
Assessment of Adipocyte Function in Women with PCOS
批准号:
7334641
负责人:
DAVID A EHRMANN
金额:
$18.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2012-08-31
关键词:
11pAddressAdenovirusesAdipocytesAdipose tissueAffectAgeAgonistAmericanAndrogensBeta CellBiological AssayBiopsyBlood specimenBody mass indexBranched-Chain Amino AcidsBreathingCardiovascular DiseasesCollaborationsComplementComplexConditionConsumptionContinuous Positive Airway PressureCortisoneDataDevelopmentDiseaseDyslipidemiasElevationEnergy MetabolismEnzymesEstrogensEventExcisionFamilyFatty acid glycerol estersFeeding behaviorsGenderGlucocorticoid ReceptorGlucocorticoidsGlucoseGlucose IntoleranceGonadal Steroid HormonesHealthHepaticHeritabilityHormonalHormonesHumanHydrocortisoneHypertensionImmunoblottingImpairmentIn VitroIncidenceInsulinInsulin ResistanceInterventionKineticsLaboratoriesLeptinLeuprolideLipidsLipolysisLiverLocalizedLuciferasesMeasuresMediationMetabolicMetabolic PathwayMetabolic syndromeMetabolismMethodologyMolecularMuscleMutationNonesterified Fatty AcidsNumbersObesityObstructive Sleep ApneaOutcomeOvarianOvarian AblationPancreasPathogenesisPathologicPathologyPatientsPersonal SatisfactionPharmaceutical PreparationsPhysiologicalPlasmaPlayPolycystic Ovary SyndromePrincipal InvestigatorProductionProgesteroneProtein OverexpressionProtocols documentationREM SleepRandomizedRegulationReporterReportingResearch DesignResearch PersonnelResponse ElementsRisk FactorsRoleSatiationSex CharacteristicsSignal TransductionSkeletal MuscleSleepSleep Apnea SyndromesSlow-Wave SleepTestingTherapeutic InterventionTimeTissuesTriglyceride MetabolismTriglyceridesUniversitiesUrineWeekWeightWomanWorkacylcarnitineadenoviral-mediatedadiponectinbaseblood glucose regulationcardiovascular risk factordaydesignearly onsetgenetic manipulationglucose metabolismimprovedin vitro Assayin vivoinsightinsulin secretioninsulin sensitivityinsulin signalinginsulin tolerancelipid biosynthesislipid metabolismmenmetabolomicsnon rapid eye movementnovelprogramsreproductiveresearch studyresistinsmall hairpin RNAtoolxenoestrogen
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Polycystic ovary syndrome (PCOS) affects up to 10% of women of reproductive age, and is characterized by
elevation in circulating androgen levels, insulin resistance, dyslipidemia and obesity. However, the
molecular mechanisms that underlie the development of the metabolic syndrome in PCOS remain unclear.
The interplay between PCOS and obstructive sleep apnea (OSA) in women may play a critical but under
appreciated role in these pathologies. Despite the recent linkage between OSA and insulin resistance, and
the finding that obese women with PCOS are up to 30 times more likely to develop OSA as weight matched
women without PCOS, most of the studies on OSA and metabolism have been conducted in men. The
central hypothesis of this application is that OSA is a novel risk factor for the development of insulin
resistance in adipose tissue in women with PCOS. We will test this hypothesis by measuring insulin
sensitivity in primary adipocytes from obese PCOS women with OSA, before and after therapeutic
intervention for the OSA. Insulin signal transduction and regulation of lipid metabolism will be assayed in
vitro and compared to values obtained in vivo. Additionally, we will determine the role alterations in
circulating glucocorticoids and the localized activation of glucocorticoids in adipocytes by the enzyme 110-
HSD1 on adipocytic insulin action. Finally, the effects of modulating reducing endogenous ovarian androgen
production on insulin signaling in adipocytes from obese PCOS women with OSA will be determined, as will
the effects of giving exogenous estrogen or progesterone to patients. Together, these studies will comprise
an integral part of a larger SCOR application that will undertake a comprehensive examination of the role of
OSA and circulating androgen on the development on insulin resistance, obesity and the metabolic
syndrome in women with PCOS.
Relevance: Women with PCOS suffer from obesity, metabolic syndrome, dysregulation of sex steroid
synthesis and obstructive sleep apnea. However, the inter connections between these various disorders is
not well understood. As part of an integrative collaborative project, this application will directly investigate
the effects of OSA and androgens on insulin sensitivity in adipocyte biopsies from PCOS patients before and
after therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8864376
-
项目类别:
-
资助金额:$26.07万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, Body Fat, and Plasma Triglycerides in Women
-
批准号:8326136
-
项目类别:
-
资助金额:$34.85万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8247929
-
项目类别:
-
资助金额:$70.97万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8698745
-
项目类别:
-
资助金额:$63.03万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8669442
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8535748
-
项目类别:
-
资助金额:$54.23万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8335414
-
项目类别:
-
资助金额:$60.7万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8530646
-
项目类别:
-
资助金额:$55.12万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Administrative Core
-
批准号:7334637
-
项目类别:
-
资助金额:$17.14万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
-
批准号:7678045
-
项目类别:
-
资助金额:$119.14万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
-
批准号:7928876
-
项目类别:
-
资助金额:$121.03万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
GENETICS OF PCOS
-
批准号:7604742
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, Body Fat, and Plasma Triglycerides in Women
-
批准号:7334640
-
项目类别:
-
资助金额:$28.49万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
PCOS, Sleep Apnea, and Metabolic Risk in Women
-
批准号:7334639
-
项目类别:
-
资助金额:$25.86万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
-
批准号:7504105
-
项目类别:
-
资助金额:$115.82万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
-
批准号:7288418
-
项目类别:
-
资助金额:$116.19万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sleep and Metabolism in Obesity: Impact of Gender
-
批准号:7334638
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
-
批准号:8134784
-
项目类别:
-
资助金额:$119.38万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
SLEEP AND PCOS
-
批准号:7604763
-
项目类别:
-
资助金额:$7.66万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
PIOGLITAZONE & ETHINYL ESTRADIOL/DROSPERINONE IN THE TREATMENT OF PCOS
-
批准号:7604775
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
海外基金